16
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Clinical and Biochemical Aspects of Pheochromocytoma

      research-article
      ,
      Cardiology
      S. Karger AG
      Symptomatology, Preoperative localization, Pheochromocytoma, Catecholamines, Catecholamine metabolites

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In 110 patients the diagnosis of pheochromocytoma was established by biochemical tests. These patients displayed various patterns of urinary and plasma catecholamines and their metabolites. The estimation of urinary methoxycatecholamines proved the most useful screening procedure. In patients with equivocal biochemical results the clonidine suppression test appeared to be a useful diagnostic tool. Clinical analysis displayed a bizzare course and unusual symptoms and signs in some patients. Computerized tomography and adrenal scintigraphic imaging with <sup>131</sup>I-meta-iodobenzylguanidine were found to be the most reliable non-invasive methods for localization of the tumor.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          978-3-8055-4079-7
          978-3-318-00139-6
          0008-6312
          1421-9751
          1985
          1985
          11 November 2008
          : 72
          : Suppl 1
          : 131-136
          Affiliations
          Department of Hypertension and Angiology, Academy of Medicine, Warsaw, Poland
          Article
          173959 Cardiology 1985;72:131–136
          10.1159/000173959
          3931914
          22b6784d-027a-4c15-8415-41455d890b87
          © 1985 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Page count
          Pages: 6
          Categories
          Paper

          General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
          Pheochromocytoma,Symptomatology,Catecholamine metabolites,Preoperative localization,Catecholamines

          Comments

          Comment on this article